trial
as of 2026-07-01"Multimodal Prevention of Psychosis - Investigating Efficacy of N-Acetylcysteine and Psychotherapy in CHR-Patients"
NCTId NCT03149107
at a glance
Phase 3 · Terminated
Enrollment 48 (actual)
Sponsored by University Hospital, Bonn
Primary completion 2021-01
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 3
Status
Terminated
Enrollment
48 (actual)
Study type
Interventional
Allocation
Randomized
Model
Factorial
Masking
Triple
Start
2016-09-01
Primary completion
2021-01
Eligibility
ALL · 18 Years · 40 Years
Interventions & indications
Sponsors
University Hospital, BonnLead Sponsor
University of CologneCollaborator
Central Institute of Mental Health, MannheimCollaborator
Ludwig-Maximilians - University of MunichCollaborator
University Hospital TuebingenCollaborator
Heinrich-Heine University, DuesseldorfCollaborator
Charite University, Berlin, GermanyCollaborator
RWTH Aachen UniversityCollaborator
Sites
10 total
Mannheim, GermanyTübingen, GermanyMünchen, GermanyAachen, GermanyBonn, GermanyCologne, GermanyDüsseldorf, GermanyAlzey, GermanyBerlin, GermanyBerlin, Germany
Linked catalysts
1
Facts & assertions
4 sourced
Enrollment
48
Phase
PHASE3
Primary Completion Date
2021-01
Status
TERMINATED
relationships
The graph out of here
drug
lead_sponsor
company
collaborator
indication